| Literature DB >> 33812776 |
Frank A Buquicchio1, Ansuman T Satpathy2.
Abstract
CRISPR-Cas9 technologies have transformed the study of genetic pathways governing cellular differentiation and function. Recent advances have adapted these methods to immune cells, which has accelerated the pace of functional genomics in immunology and enabled new avenues for the design of cellular immunotherapies for cancer. In this review, we summarize recent developments in CRISPR-Cas9 technology and discuss how they have been leveraged to discover and manipulate novel genetic regulators of the immune system. We envision that these results will provide a valuable resource to aid in the design, implementation, and interpretation of CRISPR-Cas9-based screens in immunology and immuno-oncology.Entities:
Mesh:
Year: 2021 PMID: 33812776 PMCID: PMC9345562 DOI: 10.1016/j.it.2021.03.003
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 19.709